Picture loading failed.

Anti-CD33 therapeutic antibody (Pre-made Gemtuzumab biosimilar,Whole mAb ADC) is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).

Gemtuzumab ozogamicin, sold under the brand name Mylotarg, is an antibody-drug conjugate (a drug-linked monoclonal antibody) that is used to treat acute myeloid leukemia.

Order informatioin


Delivery impact due to the Coronavirus Outbreak

With the COVID-19 outbreak in the world, many flights have been cancelled. In order for the customer to receive the goods properly, we use the FedEx Customized Freight (FCF) of Fedex which demands a higher fee. If the delivery fee is more expensive in your area, we will contact you by mail.

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-239-1mg 1mg 3090
GMP-Bios-ab-239-10mg 10mg 21890
GMP-Bios-ab-239-100mg 100mg 148000
GMP-Bios-ab-239-xmg ≥100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Anti-CD33 therapeutic antibody (Pre-made Gemtuzumab biosimilar,Whole mAb ADC)
INN Name Gemtuzumab
TargetCD33
FormatWhole mAb ADC
DerivationHumanized
Species ReactivityHuman
CH1 IsotypeIgG4
VD LCKappa
Highest_Clin_Trial (Jan '20)Approved
Est. StatusNFD
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2016
Year Recommended2017
CompaniesUCB;Celgene Corporation;Pfizer;University of California San Diego
Conditions ApprovedAcute myeloid leukaemia
Conditions Activena
Conditions Discontinuedna
Development Techna